These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 27869748)
1. Design of New Antibacterial Enhancers Based on AcrB's Structure and the Evaluation of Their Antibacterial Enhancement Activity. Song Y; Qin R; Pan X; Ouyang Q; Liu T; Zhai Z; Chen Y; Li B; Zhou H Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869748 [TBL] [Abstract][Full Text] [Related]
2. Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC. Li B; Yao Q; Pan XC; Wang N; Zhang R; Li J; Ding G; Liu X; Wu C; Ran D; Zheng J; Zhou H J Antimicrob Chemother; 2011 Apr; 66(4):769-77. PubMed ID: 21393180 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of the antibacterial enhancement activities of amino dihydroartemisinin derivatives. Wu C; Liu J; Pan X; Xian W; Li B; Peng W; Wang J; Yang D; Zhou H Molecules; 2013 Jun; 18(6):6866-82. PubMed ID: 23752470 [TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel 4-substituted quinazoline-2-carboxamide derivatives targeting AcrB to reverse the bacterial multidrug resistance. Gu X; Pisoni LA; Wang Y; Song D; Sykes MJ; Qin Y; Semple SJ; Polyak SW; Venter H; Ma S Bioorg Chem; 2020 Dec; 105():104394. PubMed ID: 33120321 [TBL] [Abstract][Full Text] [Related]
5. The challenge of intracellular antibiotic accumulation, a function of fluoroquinolone influx versus bacterial efflux. Vergalli J; Atzori A; Pajovic J; Dumont E; Malloci G; Masi M; Vargiu AV; Winterhalter M; Réfrégiers M; Ruggerone P; Pagès JM Commun Biol; 2020 Apr; 3(1):198. PubMed ID: 32346058 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance. Wang Y; Mowla R; Guo L; Ogunniyi AD; Rahman T; De Barros Lopes MA; Ma S; Venter H Bioorg Med Chem Lett; 2017 Feb; 27(4):733-739. PubMed ID: 28129976 [TBL] [Abstract][Full Text] [Related]
7. Boosting the Antibacterial Activity of Azithromycin on Multidrug-Resistant Al-Marzooq F; Ghazawi A; Daoud L; Tariq S Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240007 [TBL] [Abstract][Full Text] [Related]
8. Phytochemicals increase the antibacterial activity of antibiotics by acting on a drug efflux pump. Ohene-Agyei T; Mowla R; Rahman T; Venter H Microbiologyopen; 2014 Dec; 3(6):885-96. PubMed ID: 25224951 [TBL] [Abstract][Full Text] [Related]
9. Vestibules are part of the substrate path in the multidrug efflux transporter AcrB of Escherichia coli. Husain F; Bikhchandani M; Nikaido H J Bacteriol; 2011 Oct; 193(20):5847-9. PubMed ID: 21856849 [TBL] [Abstract][Full Text] [Related]
10. Covalently linked trimer of the AcrB multidrug efflux pump provides support for the functional rotating mechanism. Takatsuka Y; Nikaido H J Bacteriol; 2009 Mar; 191(6):1729-37. PubMed ID: 19060146 [TBL] [Abstract][Full Text] [Related]
11. Covalently linked AcrB giant offers a new powerful tool for mechanistic analysis of multidrug efflux in bacteria. Zgurskaya HI J Bacteriol; 2009 Mar; 191(6):1727-8. PubMed ID: 19136595 [No Abstract] [Full Text] [Related]
12. Single nucleotide polymorphism analysis of the major tripartite multidrug efflux pump of Escherichia coli: functional conservation in disparate animal reservoirs despite exposure to antimicrobial chemotherapy. Elkins CA; Mullis LB; Lacher DW; Jung CM Antimicrob Agents Chemother; 2010 Mar; 54(3):1007-15. PubMed ID: 20038628 [TBL] [Abstract][Full Text] [Related]
13. Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance. Mowla R; Wang Y; Ma S; Venter H Biochim Biophys Acta Biomembr; 2018 Apr; 1860(4):878-886. PubMed ID: 28890187 [TBL] [Abstract][Full Text] [Related]
14. Synergistic Activity of Fluoroquinolones Combining with Artesunate Against Multidrug-Resistant Wei S; Yang Y; Tian W; Liu M; Yin S; Li J Microb Drug Resist; 2020 Jan; 26(1):81-88. PubMed ID: 31738637 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of a series of 5-methoxy-2,3-naphthalimide derivatives as AcrB inhibitors for the reversal of bacterial resistance. Jin C; Alenazy R; Wang Y; Mowla R; Qin Y; Tan JQE; Modi ND; Gu X; Polyak SW; Venter H; Ma S Bioorg Med Chem Lett; 2019 Apr; 29(7):882-889. PubMed ID: 30755336 [TBL] [Abstract][Full Text] [Related]
16. A fluorescent microplate assay quantifies bacterial efflux and demonstrates two distinct compound binding sites in AcrB. Iyer R; Ferrari A; Rijnbrand R; Erwin AL Antimicrob Agents Chemother; 2015 Apr; 59(4):2388-97. PubMed ID: 25645845 [TBL] [Abstract][Full Text] [Related]
17. Substrate-dependent transport mechanism in AcrB of multidrug resistant bacteria. Jewel Y; Van Dinh Q; Liu J; Dutta P Proteins; 2020 Jul; 88(7):853-864. PubMed ID: 31998988 [TBL] [Abstract][Full Text] [Related]
18. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives. Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576 [TBL] [Abstract][Full Text] [Related]